Dr. John BoulosSynthesis of Selective Muscarinic Agonists for Alzheimer's Application

Research Objectives

The main objective of this research is to involve both chemistry and biology students at Barry University with synthetic organic research. The specific aims of the research project are:

To design and synthesize M1 selective muscarinic agonists. Series of heterocyclic compounds are being synthesized and tested based upon a theoretical model of the structural requirements for muscarinic receptor activity. The compounds are intended as mimics of acetylcholine and other cholinergic agonists at muscarinic receptors in the brain. Muscarinic M1 receptors are currently therapeutic targets for the symptomatic treatment of Alzheimer's disease.

To obtain information about the muscarinic pharmacophore by synthesizing analogs of pilocarpine, a partial muscarinic agonist currently in use to treat glaucoma.

Oh oh ....

We are sorry but it appears that JavaScript is disabled on your browser.Our site is very interactive and it requires JavaScript to be enabled.Click on the link below for instructions on how to enable JavaScript on your browser.